{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-104000","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2025-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.594458+00:00","generated_at":"2026-05-17T01:24:14.158247+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Liquidia licenses Vectura's nebulizer device for treprostinil L606 in US PAH/PH-ILD","bullets":["Upfront payment $2M; development milestones up to $12M; sales milestones up to $92.5M.","Royalties in mid-single digits; Vectura to manufacture and supply the device.","Exclusive US rights for treprostinil products treating hypertension and interstitial lung diseases (PAH, PH-ILD).","Rights of first negotiation for additional territories and indications during term.","Term until expiration of Royalty Term; termination for material breach, discontinuation, or patent challenge."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-104000","json":"https://secwatch.observer/filing/0001104659-25-104000.json","markdown":"https://secwatch.observer/filing/0001104659-25-104000.md","text":"https://secwatch.observer/filing/0001104659-25-104000.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925104000/0001104659-25-104000-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925104000/tm2529678d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:24:14.158247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}